Cargando…

Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs

Vesicular stomatitis virus (VSV) expressing the Ebola virus (EBOV) glycoprotein (GP) in place of the VSV glycoprotein G (VSV/EBOV-GP) is a promising EBOV vaccine candidate which has already entered clinical phase 3 studies. Although this chimeric virus was tolerated overall by volunteers, it still c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Locher, Samira, Schweneker, Marc, Hausmann, Jürgen, Zimmer, Gert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152369/ https://www.ncbi.nlm.nih.gov/pubmed/29869979 http://dx.doi.org/10.1099/jgv.0.001085

Ejemplares similares

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016)

Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein
Publicado: (1979)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

Emerging Biomedical Applications of the Vesicular Stomatitis Virus Glycoprotein
por: Rehman, Sheeba, et al.
Publicado: (2022)

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
por: Wong, Gary, et al.
Publicado: (2014)

Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
por: Hu, Qiang, et al.
Publicado: (2023)

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
por: Suder, Ellen, et al.
Publicado: (2018)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
por: Saito, Takeshi, et al.
Publicado: (2020)

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
por: Zettl, Ferdinand, et al.
Publicado: (2020)

High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
por: Morozov, Igor, et al.
Publicado: (2021)

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
por: Rupani, Neil, et al.
Publicado: (2022)

The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes
Publicado: (1981)

A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses
por: Farzani, Touraj Aligholipour, et al.
Publicado: (2020)

Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice
por: Park, Jung-Eun, et al.
Publicado: (2021)

Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin
por: Westcott, Marlena M., et al.
Publicado: (2018)

The synthetic futures of vesicular stomatitis virus
por: Overend, Christopher, et al.
Publicado: (2012)

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008)

Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes
por: Cutts, Todd A., et al.
Publicado: (2020)

Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing
por: Izumida, Mai, et al.
Publicado: (2020)

Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo
por: Beier, Kevin T., et al.
Publicado: (2013)

Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice
por: Zhang, Minmin, et al.
Publicado: (2016)

The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells
por: Brinkmann, Constantin, et al.
Publicado: (2017)

Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice
por: Stubbs, Sarah Hulsey, et al.
Publicado: (2021)

Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine
por: Grant-Klein, Rebecca J., et al.
Publicado: (2019)

A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon
por: Berger Rentsch, Marianne, et al.
Publicado: (2011)

EFFECT OF FORMALIN ON THE VIRUS OF VESICULAR STOMATITIS OF HORSES
por: Olitsky, Peter K., et al.
Publicado: (1928)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
por: Poetsch, Joseph H, et al.
Publicado: (2019)

Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies
por: Logan, Nicola, et al.
Publicado: (2016)

Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum
por: Pipperger, Lisa, et al.
Publicado: (2019)

Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate
por: LEE, Hyang-Sim, et al.
Publicado: (2020)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
por: Zhu, Wenjun, et al.
Publicado: (2022)

Immunocytochemical analysis of the transfer of vesicular stomatitis virus G glycoprotein from the intermediate compartment to the Golgi complex
Publicado: (1992)

Vesicular stomatitis virus glycoprotein, albumin, and transferrin are transported to the cell surface via the same Golgi vesicles
Publicado: (1983)

Inhibition of vesicular stomatitis virus infection by spike glycoprotein. Evidence for an intracellular, G protein-requiring step
Publicado: (1980)

Transport of the membrane glycoprotein of vesicular stomatitis virus to the cell surface in two stages by clathrin-coated vesicles
Publicado: (1980)

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2012)

Identification of epitopes associated with different biological activities on the glycoprotein of vesicular stomatitis virus by use of monoclonal antibodies
por: Nagata, S., et al.
Publicado: (1992)

Capping of vesicular stomatitis virus pre-mRNA is required for accurate selection of transcription stop–start sites and virus propagation
por: Ogino, Tomoaki
Publicado: (2014)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
por: Cham, Lamin B., et al.
Publicado: (2019)

Effect of sulfhydryl reagents on the infectivity of vesicular stomatitis virus
por: Beatrice, Sara T., et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_seghmq4v3h9v0daagikiptn8uq